Inner Mongolia Huihuang Pharmaceutical Co., Ltd., established in January 2022, has a registered capital of 8 million yuan. Guided by the business philosophy of "people-oriented, green economy, and sustainable development," and the corporate spirit of "innovation, integrity, and responsibility," the company is based in Yuanbaoshan District, Chifeng City, Inner Mongolia. It focuses on regions such as Northeast and North China, pursuing a development path of specialization, scale, and high-tech industrialization to achieve both corporate value and social benefits.

The company is located in the Development and Testing Zone of Yuanbaoshan District, Chifeng City, Inner Mongolia. The planned total site area of the enterprise is 43,333.54 square meters (65.00 acres), with a total building area of 11,567.92 square meters and a total floor area of 23,135.84 square meters. The plot ratio is 0.53, the building density is 66.33%, and the proportion of land used for administrative offices and living facilities is 5.92%. The total investment amounts to 130 million yuan.

The main products include active pharmaceutical ingredients: alpha-lipoic acid, parecoxib; pharmaceutical intermediates: 3-bromopyridine, 5-bromouracil, 4-chloro-2-fluorotoluene, tert-butyl bromoacetate, 2,3,4-trihydroxybenzaldehyde, bromothymol blue.